Accuray Incorporated (LON:0H8I)
London · Delayed Price · Currency is GBP · Price in USD 0.5086
+0.0038 (0.75%)
Feb 12, 2026, 4:25 PM GMT
Accuray Market Cap
Accuray has a market cap or net worth of 42.56 million as of February 12, 2026. Its market cap has decreased by -76.30% in one year.
Market Cap
42.56M
Enterprise Value
139.98M
Revenue
324.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.51
Market Cap Chart
Since February 8, 2007, Accuray's market cap has decreased from 759.37M to 42.56M, a decrease of -94.40%. That is a compound annual growth rate of -14.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 44.66M | -35.69% |
| Dec 31, 2025 | 69.44M | -56.34% |
| Dec 31, 2024 | 159.05M | -26.25% |
| Dec 29, 2023 | 215.67M | 32.58% |
| Dec 30, 2022 | 162.67M | -49.21% |
| Dec 31, 2021 | 320.28M | 14.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Hemogenyx Pharmaceuticals | 57.51M |
| SkinBioTherapeutics | 51.13M |
| BATM Advanced Communications | 51.01M |
| hVIVO | 48.31M |